home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Inflammatory Mutation Found In Liver Cancer

  November, 26 2008 18:23
your information resource in human molecular genetics

A type of mutation that 'switches on' inflammatory signalling pathways in human liver tumours is described in a paper in Nature. Similar mutations may occur in other inflammatory epithelial cancers.

Jessica Zucman-Rossi and colleagues studied human inflammatory hepatocellular adenomas (IHCAs), benign liver tumours with a strong inflammatory signature. 'Gain-of-function' mutations in the gp130 signalling component of the interleukin-6 receptor - a pro-inflammatory signalling pathway - were found in around 60% of IHCAs.

The gp130 alterations were accompanied by mutations that activate beta-catenin, a molecule already implicated in the development of liver cancer. So it's thought that the two mutations cooperate to promote tumour formation.


Jessica Zucman-Rossi (Institut National de la Sante et la Recherce Medicale, Paris, France)
E-mail: zucman@cephb.fr

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.